Dianthus Therapeutics, Inc. · NASDAQ:DNTH

Fairmount Funds Management LLC reported a 9.90% stake in Dianthus Therapeutics, Inc. (Schedule 13D/A)

Event Sep 11, 2025 · Filed Sep 15, 2025

Fairmount Funds Management LLC reported a 9.90% stake in Dianthus Therapeutics, Inc., 4,052,052 shares, with active intent on Sep 11, 2025. Filed Sep 15, 2025 (Schedule 13D/A).

Stake
9.90%
Shares
4,052,052
Intent
Active
What changed
Stake changed
Filed together
5 holders

The filing in full

HolderStakeShares
Fairmount Funds Management LLC9.90%4,052,052
Fairmount Healthcare Fund II L.P.9.90%4,052,052
Fairmount SPV III, LLC0%0
Peter Evan Harwin9.90%4,052,052
Tomas Kiselak9.90%4,052,052

Source

View original at SEC

Related